Elisseeff, Jennifer H
- Johns Hopkins University · Ophthalmology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,634
- Rising Star
- Sustained Excellence
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Ophthalmology
NIH Funding · FY2023
Linked Award Amount
$1.8M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#4,634
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Elisseeff, Jennifer H as a PI. Multi-PI records show the full award amount for context.
- 5DP1AR076959-05DP1Contact PIBiomaterials-directed regenerative immunotherapiesJohns Hopkins University · Ophthalmology (NIH department code)$1.1Maward amount
- 5R01EB028796-04R01Contact PISingle cell characterization of the biomaterial immune and stromal responseJohns Hopkins University · Ophthalmology (NIH department code)$612.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Elisseeff, Jennifer H as a PI.
FY2023 award administered by Johns Hopkins University (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardJohns Hopkins University
- 2008$500K Cumulative Funding
- 2008Entered Top 50% NationallyRanked #6929
- 2009$1M Cumulative Funding
- 2011$2M Cumulative Funding
- 2012R01 Grant Holder
- 2019$5M Cumulative Funding
- 2019Entered Top 25% NationallyRanked #4164
- 2022$10M Cumulative Funding